Keyphrases
Animal Development
8%
Apoptosis Inhibition
8%
Apoptotic Cell Death
16%
Binding Protein
8%
Cancer Cells
8%
Cancer Treatment
16%
Caspase
8%
CDC25 Phosphatases
8%
Cell Cycle Arrest
8%
Cell Cycle Checkpoint
16%
Cell Cycle Control
8%
Cell Cycle Progression
25%
Cell Cycle Regulation
33%
Cell Death
16%
Cell Division
8%
Cellular Response
8%
Checkpoint Activation
8%
Checkpoint Kinase 1 (CHK1)
100%
Checkpoint Mechanisms
16%
Checkpoint Response
16%
Chk2
50%
Chromatin Condensation
8%
Chromosome Segregation
8%
Control Response
8%
Cyclin-dependent Kinase 1 (CDK1)
16%
Cyclin-dependent Kinase 5 (Cdk5)
8%
Cytokinesis
8%
Damage Signaling
8%
Daughter Cells
8%
Defective Cell
8%
DNA Damage
66%
DNA Damage Response
33%
DNA Integrity
8%
DNA Repair
8%
DNA Topoisomerase
8%
Downstream Effectors
8%
Enzymatic Activity
8%
Etoposide
16%
Functional Studies
100%
G2 Arrest
8%
G2-M Checkpoint
8%
Genetic Material
8%
Genome Stability
8%
Genomic Instability
16%
Human Disease
8%
In Cancer
8%
Ionizing Irradiation
8%
Kinase Activation
8%
Kinase Activity
16%
M Phase
8%
Mitosis
8%
Mitotic Cell Death
8%
Mitotic Entry
16%
Negative Regulator
8%
Novel Protein
33%
Novel Regulator
100%
Novel Therapeutic Targets
16%
Oncogenesis
8%
Overexpression
16%
Phase Correction
8%
Potent Inhibitor
8%
Potential Utilization
8%
Protein Kinase
8%
Public Health
8%
Putative Drug Targets
8%
Regulatory Mechanism
16%
Sigma Phase
8%
Site-directed mutation
8%
Tissue Homeostasis
16%
Tumor Cells
8%
Tumorigenesis
16%
Biochemistry, Genetics and Molecular Biology
Binding Protein
16%
Cancer Cell
16%
Carcinogenesis
50%
Caspase
16%
Cell Cycle
100%
Cell Cycle Arrest
16%
Cell Cycle Checkpoint
50%
Cell Cycle M Phase
16%
Cell Cycle Progression
50%
Cell Cycle Regulation
33%
Cell Death
50%
Cell Division
16%
Chromatin Condensation
16%
Cyclin-Dependent Kinase 1
33%
Daughter Cell
16%
DNA Damage
50%
DNA Damage Checkpoint
33%
DNA Damage Response
100%
DNA Gyrase
16%
DNA Repair
16%
Enzyme Activity
16%
G2 Phase Cell Cycle Checkpoint
16%
Genetics
16%
Genome Instability
50%
Homeostasis
33%
Kinase
50%
P53
33%
Phosphotransferase
50%
Programmed Cell Death
50%
Promoter Region
16%
Protein Kinases
16%
Protein Tyrosine Phosphatase
16%
S Phase
16%